<http://schema.org/description>
"Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2014-06-mm-added-standard-treatment-survival.html>